QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.056499v1 307/3/1234    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Imai, T. Articles by Otagiri, M. Search for Related Content PubMed PubMed Citation Articles by Imai, T. Articles by Otagiri, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITROPHENOLS PROPRANOLOL HYDROCHLORIDE

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Evidence for the Involvement of a Pulmonary First-Pass Effect via Carboxylesterase in the Disposition of a Propranolol Ester Derivative after Intravenous Administration

Faculty of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan (T.I., Y.Y., M.O.); and Faculty of Pharmaceutical Sciences, Chiba University, Chiba, Japan (M.H., K.C.)

The disposition kinetics of O-butyryl propranolol (butyryl-PL), a model compound containing an ester moiety, after intravenous administration was compared with that of PL in rats and beagle dogs. Rats showed only 30% conversion of butyryl-PL to PL up to 2 h after dosing, whereas dogs showed nearly complete conversion within 10 min after administration. The CL_total of butyryl-PL in rats was 5.8 l/h/kg and that in dogs was 65.6 ± 18.6 l/h/kg, both of which were greater than hepatic blood flow. The in vivo conversion from butyryl-PL to PL in the rat could be explained on the basis of the hydrolysis characteristics in the liver and blood. The in vitro hydrolysis data and the in vivo data after intra-arterial administration clearly demonstrated that the extremely high CL_total of butyryl-PL in dogs was dependent on first-pass hydrolysis in the lung in addition to hydrolysis at a blood flow-limited rate in the liver and kidney. The availability of butyryl-PL after passage through the lung was 50%. Furthermore, the isoform of carboxylesterase involved in the pulmonary hydrolysis of butyryl-PL in the dog was identified as D1, a CES-1 group enzyme. However, butyryl-PL was not recognized as a substrate by CES-1 family carboxylesterases, which are present at high levels in the rat lung (RH-1) and kidney (RL-1). These findings indicate that extrahepatic metabolism, especially in the lung, is important in the disposition of drugs containing an ester moiety after intravenous administration and that the substrate specificity of carboxylesterase isozyme distinguishes from others.

Address correspondence to: Dr. Teruko Imai, Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan. E-mail: iteruko{at}gpo.kumamoto-u.ac.jp

This article has been cited by other articles:

				C. Jewell, C. Ackermann, N. A. Payne, G. Fate, R. Voorman, and F. M. Williams Specificity of Procaine and Ester Hydrolysis by Human, Minipig, and Rat Skin and Liver Drug Metab. Dispos., November 1, 2007; 35(11): 2015 - 2022. [Abstract] [Full Text] [PDF]